Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Total Liabilities (2016 - 2025)

Aethlon Medical filings provide 15 years of Total Liabilities readings, the most recent being $2.2 million for Q1 2025.

  • On a quarterly basis, Total Liabilities fell 9.83% to $2.2 million in Q1 2025 year-over-year; TTM through Mar 2025 was $2.2 million, a 9.83% decrease, with the full-year FY2025 number at $2.2 million, down 9.83% from a year prior.
  • Total Liabilities hit $2.2 million in Q1 2025 for Aethlon Medical, up from $2.2 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $3.4 million in Q4 2022 to a low of $974348.0 in Q3 2021.
  • Median Total Liabilities over the past 5 years was $2.4 million (2023), compared with a mean of $2.3 million.
  • Biggest five-year swings in Total Liabilities: crashed 34.6% in 2021 and later soared 226.27% in 2022.
  • Aethlon Medical's Total Liabilities stood at $1.4 million in 2021, then surged by 153.91% to $3.4 million in 2022, then fell by 17.99% to $2.8 million in 2023, then fell by 22.45% to $2.2 million in 2024, then rose by 2.05% to $2.2 million in 2025.
  • The last three reported values for Total Liabilities were $2.2 million (Q1 2025), $2.2 million (Q4 2024), and $2.8 million (Q3 2024) per Business Quant data.